Recent

% | $
Quotes you view appear here for quick access.

Zynga, Inc. Message Board

jonas_tyrell 15 posts  |  Last Activity: May 28, 2015 5:18 PM Member since: Mar 8, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • This isn't about a failed test, it's about a FAILED SYSTEM.
    Failure, not only from the perspective of a corrupt and inept insurance bureaucracy but also from an intransigent (and perhaps corrupted) legal system that has failed to protect American Intellectual Property especially as it relates to discoveries in diagnostic field of medicine.

    It appears that the legal system here has truly failed this company and as such, is about to fail us as a nation if they are unable to find a way to litigate ownership and its justification for the discovery of novel new approaches in medical diagnostics. Perhaps this means that the Myriad itself must be challenged but whatever it takes, they had better act soon before America loses it's ability to compete against the rest of the world as it relates to the lowest bidder across continents when no ownership of methods and ideas is the default.

    Facts are facts and this company and it's shareholders have been gamed for years but this cannot all be blamed in its entirety upon our management team. Much of the failure of SensiGene is inexplicably inherent in the management of our legal system and the slovenly manner it has taken in dealing with this issue of Diagnostic Patent Protection. They are slow to rule because, as someone here once said; they are afraid of an outcome that will fall heavy upon their shoulders as this country loses countless billions in future wealth.

    Soon the court will let the world know their decision and we will know, but until then, the abuse (and the losses) continues as new corrupt entities emerge to steal our know how without having spent a dime and then undercut us in the market place to the point of insolvency - because they CAN.

    I believe they will ultimately US judges will make the right decision.

    Sentiment: Strong Buy

  • jonas_tyrell jonas_tyrell May 28, 2015 12:24 AM Flag

    The consolidation and dissolution of the operation in Chicago (which wasnt adding a dime to the bottom line but costing us Millions) is a good thing. The fix is in, our primary revenue until further notice is going to stem from royalties paid to us passively thru the ILMN revenue sharing agreement. To be "relieved" of the tremendous financial obligations of this fruitless facility going forward will be adding between 20% to 30% to our net revenue following the write down. Not too shabby. A smart albeit painful move perhaps but no one could argue the fact that this is indeed "shareholder friendly".

    Sentiment: Strong Buy

  • Reply to

    A win from the CAFC

    by ociferdibble May 18, 2015 12:28 PM
    jonas_tyrell jonas_tyrell May 18, 2015 5:29 PM Flag

    Exactly, I think one very important component Max has failed to paint into the mix is the immediate and deadly short squeeze. This company sports a very hefty short position that will not be covered in a day or even a week without seeing prices substantially above 15.00 per share.

    Sentiment: Strong Buy

  • Reply to

    Need to close above $3.73...next stop $4.14.

    by msuicehockey1983 May 18, 2015 11:40 AM
    jonas_tyrell jonas_tyrell May 18, 2015 11:47 AM Flag

    I agree msuice,
    There are so very many developments on the international front with and without ILMN that were not mentioned during the conference call because they are not 'done deals'. Never the less, they are set to be as such THIS quarter and will have a tremendously positive effect on the balance sheet.

    Sentiment: Strong Buy

  • Reply to

    CAFC Ruling

    by btommasino May 11, 2015 9:44 AM
    jonas_tyrell jonas_tyrell May 12, 2015 10:37 AM Flag

    Correction: Should have read 250 years of precedent

    Sentiment: Strong Buy

  • Reply to

    CAFC Ruling

    by btommasino May 11, 2015 9:44 AM
    jonas_tyrell jonas_tyrell May 12, 2015 10:34 AM Flag

    The judges are trying to wrap their brains around it. If they let it stand as is, they could go down as the perpetrators of the greatest harm to the idea of intellectual property within the capitalist system in the history of this country and perhaps the world. The idea that new ways of interpreting data should NOT fall under the protection of copy right could immediately slow the rate of research and development in the leading edge technologies (not just biotech, in case you haven't heard, biology, nano electronics and advanced materials are in the process of crossing the threshold into a single science as humans observe nature and copy it's processes to create new "life forms", if you will, both physically in the nano world and virtually within computers as "digital metaphor", if you will. These judges have been tasked with a heavy burden and they know it. Im sure they are stalling out of fear. Their decision could bring the biotech revolution to a screeching halt. I am gambling that they wont flush 2500 years of precedent down the drain.

    Sentiment: Strong Buy

  • jonas_tyrell by jonas_tyrell Apr 27, 2015 1:37 PM Flag

    When are they going to run out of idiots for the daily/weekly suckers play?
    Until May 4th, price is irrelevant unless you buy or sell.
    Fireworks coming then and in my opinion, a far higher likelihood shares will catapult higher as opposed to falling off a cliff.

    Sentiment: Strong Buy

  • Reply to

    Potential Takeover

    by hoyt356 Apr 5, 2015 8:56 PM
    jonas_tyrell jonas_tyrell Apr 5, 2015 9:59 PM Flag

    Big Pharma. Once in place, this type of acquisition represents bread and butter for a long, long time. If I were a betting man, I'd put it all on Roche.
    IMO, they ultimately want ILMN as well.
    Diagnostics are Diagnostics. Blood AND Stool? That's about as comprehensive as it gets.

    Sentiment: Strong Buy

  • Reply to

    Goldman Sachs games??

    by trg_1234 Mar 26, 2015 11:55 AM
    jonas_tyrell jonas_tyrell Mar 26, 2015 11:58 AM Flag

    Trg, love your glib humor. "shocked" indeed. Goldman got to be "GOLDMAN" through these kinds of machinations and brinksmanship - and they're quite good at it. All I can say is buy while it's down, you can only fly a false flag for so long before people figure out it's a fake.

    Sentiment: Strong Buy

  • It looks like they've joined ranks with the pooled interests that lost their behinds shorting this stock over the past 18 months. Still, I think it's good money after bad. They're dumping their hedges and it won't be pretty for them if any sort of good news at all hits the wires. It's a calculated gamble but I don't believe it will last too long. That would be just plain foolish IMO

    Sentiment: Strong Buy

  • Exact Sciences, the Wisconsin-based molecular laboratory, has added an impressive list of names to its roster that are providing some form of coverage or support to its colon cancer assay.
    Anthem, one of the largest health insurers in the United States, has agreed to provide coverage for Exact’s Cologuard assay to those enrollees who have an indicator for closer-than-typical colon screenings due to potential health issues. Anthem said it would pay for the test for those group of enrollees every three years. According to a coverage statement issued by the company, it considers the use of Cologuard outside of that test group to be investigational in nature and not medically necessary.
    Exact also announced earlier this month that Aetna plans to cover its Cologuard test and make it available to 967,000 members without an additional co-payment. The three-year agreement between the two companies goes into effect on April 1.
    “We look forward to working with Aetna to provide their members with a new option for colon cancer screening. Colon cancer is most treatable when caught early, underscoring the importance of routine screening,” said Exact Sciences Chief Executive Officer Kevin Conroy in a statement.
    The Cologuard assay is aimed at adults over the age of 50—the group recommended to undergo regular colon screenings. The test analyzes DNA and blood biomarkers in stool to detect both cancer and potentially precancerous conditions. The assay is not considered a replacement to a colonoscopy.

    Sentiment: Strong Buy

  • Heavy Open Interest in March 25,26 and 27 call strikes dictated that the balloon be popped or at least deflated before it floated beyond their reach. Watch for an almost vertical ascent as soon as the open interest at these strikes dries up. (likely expiration).

  • Reply to

    Shorts are on fire

    by sucktionmonkey Mar 9, 2015 12:20 PM
    jonas_tyrell jonas_tyrell Mar 9, 2015 12:23 PM Flag

    Just loaded up with a 2nd traunch at 23.52 - Thank you Suckmonk!

    Sentiment: Strong Buy

  • This will DOUBLE the existing force to about 310

    Very Nice!

    Sentiment: Hold

  • Reply to

    New direction for Josh...

    by larrydp_98 Mar 5, 2015 9:07 PM
    jonas_tyrell jonas_tyrell Mar 6, 2015 1:58 AM Flag

    Actually,I dont believe any of this is off base at all larrydp. A VERY close friend of mine, who has been working in the enterprise solution services division of (one of the majors) an unhamed mobile phone carrier says that there is a pending bandwidth crisis as the plethora of new devices and ever smarter phones, watches and tablets are gobbling up all available 4G and LTE bandwidth. These carriers are desperate to get as much of their customer's traffic OFF of 4g and LTE and onto the internet hoping to free up bandwidth for the applications and devices that can only be effective utilizing them alone. He said that they are currently working on finding solutions that will take not only the texting and low bandwidth data off of cellular networks but simultaneously re-route the VOICE traffic to Wifi enabled networks and where the latest wifi build outs make bandwidth accessible, video and IPTV as well (and we are currently seeing the industry wide investment in "mobile hot spots" by the cable networks to that end). So in one sense, OTT is not the threat, it's the savior - as the re routing of voice to VOIP as opposed to cellular will become the primary method for freeing up 4G and LTE for the applications that require them the most - the ones with limited access otherwise. The current spectrum just cannot handle the ever expanding number of devices and the bandwidth they require. Oracle realized this when they purchased Acme Packet. The battle hasn't even begun though and AUDC knows this. In my opinion AUDC is very well situated to become a primary weapon for whom ever. Once the big carriers decide to take off their gloves and fight the fight, there's the possibility of a bidding war for AudioCodes - A tiny company with a huge IP footprint. My guess is that multiple potential suitors have spoken with Shabtai by now, that its quite possible one of the largest portals may in fact, be working with the company right now to lay the groundwork for a surprise offensive.

ZNGA
2.98+0.04(+1.36%)Jun 2 4:00 PMEDT